Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective
- PMID: 28092012
- PMCID: PMC5236052
- DOI: 10.1186/s13561-016-0141-3
Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective
Abstract
ᅟ: We analyze one-year costs and savings of a telemedically supported case management program after kidney transplantation from the perspective of the German Healthcare System. Recipients of living donor kidney transplantation (N = 46) were randomly allocated to either (1) standard aftercare or (2) standard aftercare plus additional telemedically supported case management. A range of cost figures of each patient's medical service utilization were calculated at month 3, 6 and 12 and analyzed using two-part regression models. In comparison to standard aftercare, patients receiving telemedically supported case management are associated with substantial lower costs related to unscheduled hospitalizations (mean difference: €3,417.46 per patient for the entire one-year period, p = 0.003). Taking all cost figures into account, patients receiving standard aftercare are associated, on average, with one-year medical service utilization costs of €10,449.28, while patients receiving telemedically supported case management are associated with €5,504.21 of costs (mean difference: € 4,945.07 per patient, p < 0.001). With estimated expenditures of €3,001.5 for telemedically supported case management of a single patient, we determined a mean difference of €1,943.57, but this result is not statistically significant (p = 0.128). Sensitivity analyses show that the program becomes cost-neutral at around ten participating patients, and was beneficial starting at 15 patients. Routine implementation of telemedically supported case management in German medium and high-volume transplant centers would result in annual cost savings of €791,033 for the German healthcare system. Patients with telemedically supported case management showed a lower utilization of medical services as well as better medical outcomes. Therefore, such programs should be implemented in medium and high-volume transplant centers.
Trial registration: DRKS00007634 ( http://www.drks.de/DRKS00007634 ).
Keywords: Cost-benefit; Cost-of-illness; Telemedicine.
Figures
Similar articles
-
Telemedically Supported Case Management of Living-Donor Renal Transplant Recipients to Optimize Routine Evidence-Based Aftercare: A Single-Center Randomized Controlled Trial.Am J Transplant. 2017 Jun;17(6):1594-1605. doi: 10.1111/ajt.14138. Epub 2017 Jan 5. Am J Transplant. 2017. PMID: 27873477 Clinical Trial.
-
Re: Telemedically Supported Case Management of Living-Donor Renal Transplant Recipients to Optimize Routine Evidence-Based Aftercare: A Single-Center Randomized Controlled Trial.J Urol. 2017 Dec;198(6):1198-1199. doi: 10.1016/j.juro.2017.09.044. Epub 2017 Sep 19. J Urol. 2017. PMID: 29144926 No abstract available.
-
[A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].Ann Ig. 2013 Jan-Feb;25(1):43-56. doi: 10.7416/ai.2013.1905. Ann Ig. 2013. PMID: 23435779 Italian.
-
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
-
[Telemedicine in stroke care].Med Klin Intensivmed Notfmed. 2017 Nov;112(8):687-694. doi: 10.1007/s00063-017-0344-3. Epub 2017 Sep 14. Med Klin Intensivmed Notfmed. 2017. PMID: 28913684 Review. German.
Cited by
-
The Role of Telemedicine in Enhancing Chronic Kidney Disease (CKD) Management and Dialysis Care.Cureus. 2024 Mar 8;16(3):e55816. doi: 10.7759/cureus.55816. eCollection 2024 Mar. Cureus. 2024. PMID: 38590481 Free PMC article.
-
Video-Based Telemedicine for Kidney Disease Care: A Scoping Review.Clin J Am Soc Nephrol. 2021 Dec;16(12):1813-1823. doi: 10.2215/CJN.06660521. Epub 2021 Dec 7. Clin J Am Soc Nephrol. 2021. PMID: 36630403 Free PMC article.
-
Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.Cochrane Database Syst Rev. 2022 Sep 12;9(9):CD012854. doi: 10.1002/14651858.CD012854.pub2. Cochrane Database Syst Rev. 2022. PMID: 36094829 Free PMC article.
-
Detecting, preventing and treating non-adherence to immunosuppression after kidney transplantation.Clin Kidney J. 2022 Jan 14;15(7):1253-1274. doi: 10.1093/ckj/sfac017. eCollection 2022 Jul. Clin Kidney J. 2022. PMID: 35756738 Free PMC article. Review.
-
Opportunities in the cloud or pie in the sky? Current status and future perspectives of telemedicine in nephrology.Clin Kidney J. 2020 Aug 14;14(2):492-506. doi: 10.1093/ckj/sfaa103. eCollection 2021 Feb. Clin Kidney J. 2020. PMID: 33619442 Free PMC article. Review.
References
-
- Sellares J, De Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF. Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence. Am J Transplant. 2012;12:388–399. doi: 10.1111/j.1600-6143.2011.03840.x. - DOI - PubMed
-
- Gremigni P, Bacchi F, Turrini C, Cappelli G, Albertazzi A, Bitti PER. Psychological factors associated with medication adherence following renal transplantation. Clin Transpl. 2007;21:710–715. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources